Skip to main content

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • U.S. health regulators approved Praxbind, a reversal agent made by Germany Private held Boehringer Ingelheim, for use in emergency situations by patients taking the company's widely used Pradaxa blood thinner. Praxbind, an intravenous injection, is the first reversal agent approved specifically for Pradaxa and works by binding to the drug compound to neutralize it.

  •  A new radiation therapy, which has already been in use to treat prostate, brain, and head and neck cancers, also reduces chemotherapy side effects when administered in those afflicted with lung cancer, new research has found.

  • You should lose weight in case you are overweight in order to avoid cancer for a new study, which analysed data relating to more than five million people, has found links between obesity and cancer.

Subscribe to Pharma News